DiaMedica Therapeutics Inc (DMAC) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

DiaMedica Therapeutics Inc
DMAC
(Nasdaq - US)
N/A
2.63
+0.04 (+1.54%)
in:usd•As of: May 02, 2024 15:59 UTC -4
Open
2.60
High
2.63
Low
2.60

Stats

Prev. Close

2.59

Open

2.60

Day's Range

2.60 - 2.63

52 Week Range

1.58 - 4.75

YTD Change

-7.39%

1 Year Change

62.35%

Market Cap

99.83M

P/E Ratio

N/A

Volume

3,366.00

Beta

1.75

Sector

Health Technology

Industry

Pharmaceuticals Major

Economic CalendarAll Events

Time zone: GMT

Thursday, May 2nd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Nonfarm Productivity QoQ PrelQ1	Medium	0.3%	0.8%	3.5%
12:30	USD	Initial Jobless ClaimsApr/27	Medium	208K	212K	208K
12:30	USD	Unit Labour Costs QoQ PrelQ1	Medium	4.7%	3.3%	0.0%
14:00	USD	Factory Orders MoMMar	Medium	1.6%	1.6%	1.2%

Friday, May 3rd 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:30	USD	Average Hourly Earnings MoMApr	Medium		0.3%	0.3%
12:30	USD	Average Hourly Earnings YoY	Medium		4%	4.1%
12:30	USD	Participation RateApr	Medium		62.7%	62.7%

Latest News

featured

Zacks Investment ResearchApr 18, 2024

DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch

DMAC+1.54%

featured

Zacks Investment ResearchApr 15, 2024

DiaMedica Therapeutics (DMAC) Loses -19.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

DMAC+1.54%

featured

InvestorPlaceMar 23, 2024

Wall Street's Favorite Penny Stocks? 7 Names That Could Make You Filthy Rich

DMAC+1.54%

featured

Seeking AlphaMar 20, 2024

DiaMedica Therapeutics Inc. (DMAC) Q4 2023 Earnings Call Transcript

DMAC+1.54%

featured

InvestorPlaceMar 20, 2024

DMAC Stock Earnings: DiaMedica Therapeutics Meets EPS for Q4 2023

DMAC+1.54%

featured

Seeking AlphaNov 14, 2023

DiaMedica Therapeutics Inc. (DMAC) Q3 2023 Earnings Call Transcript

DMAC+1.54%

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker